Last reviewed · How we verify
NCT06006897
Pain, Physical Activity, Posture and Quality of Life in Post-COVID-19 Individuals With Idiopathic Scoliosis
trial testing Physical Evaluations of post-COVID-19 individuals in COVID-19 Respiratory Infection in 41 participants. Completed in 30 December 2024.
30 September 2024
Quick facts
| Lead sponsor | Izmir Democracy University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 41 |
| Start date | 16 June 2023 |
| Primary completion | 30 September 2024 |
| Estimated completion | 30 December 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Physical Evaluations of post-COVID-19 individuals
- Physical evaluations of non-post-COVID-19 individuals
Conditions studied
- COVID-19 Respiratory Infection — all drugs for COVID-19 Respiratory Infection →
- Idiopathic Scoliosis — all drugs for Idiopathic Scoliosis →
Sponsor
Izmir Democracy University
Who can join
18 and older, any sex, with COVID-19 Respiratory Infection or Idiopathic Scoliosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is not known to what extent the COVID-19 virus affects individuals with scoliosis during the prolonged COVID-19 pandemic. Therefore, in this study it was aimed to comparatively investigate pain severity, posture disorders that can be assessed by artificial intelligence, physical activity levels and quality of life in individuals with idiopathic scoliosis with and without COVID-19.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06006897
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Physical Evaluations of post-COVID-19 individuals
Trials testing the same drug.
- NCT06008444 — Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19 · completed
Other recruiting trials for COVID-19 Respiratory Infection
Currently open trials in the same condition.
- NCT06950177 — Pancoronavirus Vaccine Study in Healthy Adults · Phase 1 · active not recruiting
- NCT06402318 — Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine · recruiting
- NCT05765396 — SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies · active not recruiting
- NCT05689034 — Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 · Phase 2, PHASE3 · recruiting
- NCT05562505 — Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure · NA · recruiting
Other Izmir Democracy University trials
Trials by the same sponsor.
- NCT07511153 — Does the Cervical Stenosis Affect Hand Function? · not yet recruiting
- NCT07416097 — Comparison of Multidimensional Parameters in Women With Fibromyalgia and Healthy Controls · NA · not yet recruiting
- NCT07358702 — Sedentary Status and Multidimensional Outcomes in Fibromyalgia · NA · not yet recruiting
- NCT07396597 — Physical Impairments in Premature Ventricular Complex · not yet recruiting
- NCT07474623 — Effects of Nicotine Dependence on Multidimensional Health Outcomes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06006897 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Izmir Democracy University
- Last refreshed: 25 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06006897.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing